Role of the circadian clock "Death-Loop" in the DNA damage response underpinning cancer treatment resistance
N. M. Vainshelbaum, K. Salmina, B. I. Gerashchenko, M. Lazovska, P. Zayakin, M. S. Cragg, D. Pjanova, J. Erenpreisa
Abstract
The Circadian Clock (CC) drives the normal cell cycle and reciprocally regulates telomere elongation. However, it can be deregulated in cancer, embryonic stem cells (ESC), and the early embryo. Here, its role in the resistance of cancer cells to genotoxic treatments was assessed in relation to whole-genome duplication (WGD) and telomere regulation. We first evaluated the DNA damage response of polyploid cancer cells and observed a similar impact on the cell cycle to that seen in ESC - overcoming G1/S, adapting DNA damage checkpoints, tolerating DNA damage, and coupling telomere erosion to accelerated cell senescence, favouring transition by mitotic slippage into the ploidy cycle (reversible polyploidy). Next, we revealed a positive correlation between cancer WGD and deregulation of CC assessed by bioinformatics on 11 primary cancer datasets (rho=0.83; p<0.01). As previously shown, the cancer cells undergoing mitotic slippage cast off telomere fragments with TERT, restore the telomeres by recombination and return their depolyploidised mitotic offspring to TERT-dependent telomere regulation. Through depolyploidisation and the CC "death loop" the telomeres and Hayflick limit count are thus again renewed. This mechanism along with similar inactivity of the CC in early embryos support a life-cycle (embryonic) concept of cancer.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Circadian regulation of Homologous Recombination by Cryptochrome1-mediated dampening of DNA end resection
A. Romero-Franco, C. Checa-Rodriguez, … P. Huertas·bioRxiv·Jan 22, 2023
- Distinct p21 dynamics drive alternative routes to whole-genome duplication through a common CDK4/6-dependent polyploid G0 state
Yian Yang, Anuraag Bukkuri, … Wayne Stallaert·bioRxiv·Jan 15, 2026
- Pluripotency and Transcriptional Pausing Disrupt Circadian Rhythms to Facilitate the Enrichment of Cancer Stem Cells
Edward A. Gonzalez, Dahui Wang, … Jean‐Pierre Etchegaray·bioRxiv·Sep 11, 2026
- Mitotic bypass and continued endocycling promote cancer cell survival after genotoxic chemotherapy
Kevin Truskowski, Louis T.A. Rolle, … Sarah R. Amend·Cell Death and DiseasePeer-reviewed·Sep 24, 2026
- Low replication stress leads to specific replication timing advances associated to chromatin remodelling in cancer cells
L. Courtot, E. Bournique, … V. Bergoglio·bioRxiv·Aug 19, 2020
- DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer
Benjamin B. Morris, Simon Heeke, … Lauren A. Byers·Molecular CancerPeer-reviewed·Mar 20, 2025